Parallax Health Sciences Inc.

Common Stock SEC Reporting - Delinquent
OTC Pink Limited Information
Contact Info
  • 1327 Ocean Avenue
  • Suite M
  • Santa Monica, CA 90401

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2015 10-Q
CIK 0001388410
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 6770 - Blank Checks
Business Status Development Stage Company a/o Nov 09, 2012
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts
Joseph Michael Redmond CEO, President
Calli Bucci CFO, Treasurer
Kyle Withrow Secretary
Lawrence I. Washor Legal Counsel
Company Directors
David Engert Chairman
Jorn Gorlach
E. William Withrow Jr.
Anand Kumar
Joseph Michael Redmond
Company Notes
  • Formerly=Endeavor Power Corp. until 1-2014
  • Formerly=Endeavor Uranium, Inc. until 1-2009
  • Formerly=VB Trade, Inc. until 10-07
Service Providers
Accounting/Auditing Firm
David Banerjee, CPA
21860 Burbank Blvd. Suite 150
Woodland Hills, CA, 91367
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
PRLX Security Details
Share Structure
Market Value1 $13,202,605 a/o Oct 27, 2016
Authorized Shares 250,000,000 a/o Apr 20, 2015
Outstanding Shares 132,026,053 a/o Apr 20, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 26,785,990 a/o Apr 20, 2015
Par Value 0.0001
Shareholders of Record 53 a/o Apr 15, 2014
Short Selling Data
Short Interest 0 (-100%)
Aug 31, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security